| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,428 |
22,350 |
$1.52M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,545 |
5,993 |
$247K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,548 |
2,530 |
$226K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,493 |
2,461 |
$210K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,100 |
2,083 |
$189K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,126 |
7,789 |
$154K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,238 |
4,012 |
$148K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,446 |
1,334 |
$110K |
| 94060 |
|
2,610 |
2,602 |
$102K |
| 99429 |
|
2,125 |
2,112 |
$69K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,872 |
4,687 |
$67K |
| 99215 |
Prolong outpt/office vis |
808 |
801 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,699 |
2,428 |
$44K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,327 |
3,290 |
$31K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
872 |
853 |
$23K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,190 |
2,156 |
$17K |
| 0072A |
|
373 |
373 |
$14K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
195 |
195 |
$14K |
| 90461 |
|
2,691 |
2,316 |
$11K |
| 92587 |
|
812 |
807 |
$11K |
| 0003A |
|
389 |
389 |
$10K |
| 0071A |
|
257 |
256 |
$10K |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
383 |
373 |
$8K |
| 0124A |
|
181 |
181 |
$7K |
| 0154A |
|
169 |
169 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
70 |
70 |
$6K |
| 0081A |
|
161 |
160 |
$6K |
| 0074A |
|
135 |
135 |
$5K |
| 0082A |
|
129 |
128 |
$5K |
| 87807 |
|
446 |
433 |
$5K |
| 96160 |
|
1,752 |
1,750 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
47 |
47 |
$3K |
| 90480 |
|
54 |
54 |
$1K |
| 81002 |
|
391 |
354 |
$1K |
| 85018 |
|
1,037 |
1,030 |
$989.06 |
| 0002A |
|
32 |
32 |
$956.00 |
| 0083A |
|
24 |
24 |
$880.00 |
| 96112 |
|
54 |
54 |
$780.00 |
| 0001A |
|
20 |
20 |
$758.00 |
| 82947 |
|
103 |
101 |
$342.73 |
| 90686 |
|
3,677 |
3,667 |
$59.71 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
82 |
73 |
$53.18 |
| 94760 |
|
852 |
831 |
$48.76 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
2,279 |
2,217 |
$7.91 |
| 91307 |
|
1,033 |
1,024 |
$0.20 |
| 90620 |
|
607 |
603 |
$0.20 |
| 91300 |
|
609 |
604 |
$0.15 |
| 91320 |
|
104 |
103 |
$0.12 |
| 90651 |
|
570 |
570 |
$0.05 |
| 90715 |
|
167 |
167 |
$0.05 |
| 91319 |
|
128 |
128 |
$0.04 |
| 90685 |
|
498 |
492 |
$0.04 |
| 91312 |
|
185 |
185 |
$0.04 |
| 90677 |
|
199 |
199 |
$0.03 |
| 90734 |
|
538 |
536 |
$0.02 |
| 91308 |
|
364 |
359 |
$0.02 |
| 90723 |
|
793 |
790 |
$0.01 |
| 90696 |
|
56 |
56 |
$0.01 |
| 91315 |
|
159 |
158 |
$0.01 |
| 90648 |
|
1,234 |
1,228 |
$0.01 |
| 90670 |
|
960 |
955 |
$0.01 |
| 90710 |
|
46 |
46 |
$0.01 |
| 90716 |
|
90 |
90 |
$0.00 |
| 90381 |
|
135 |
135 |
$0.00 |
| 91318 |
|
70 |
69 |
$0.00 |
| 90707 |
|
106 |
106 |
$0.00 |
| 90633 |
|
606 |
605 |
$0.00 |
| 90681 |
|
275 |
274 |
$0.00 |
| 90700 |
|
84 |
83 |
$0.00 |